| human | Q5 |
| P496 | ORCID iD | 0000-0003-0815-3741 |
| P1053 | ResearcherID | W-6028-2018 |
| P69 | educated at | Yokohama City University | Q914024 |
| Jichi Medical University | Q6192089 | ||
| P108 | employer | NTT Medical Center Tokyo | Q9032184 |
| Japanese Foundation for Cancer Research | Q11264698 | ||
| Jichi Medical University Saitama Medical Center | Q24861910 | ||
| P106 | occupation | researcher | Q1650915 |
| Q40116023 | A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients |
| Q87217887 | A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia |
| Q38584425 | A retrospective analysis of computed tomography findings in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation. |
| Q48221164 | ALK positive large B-cell lymphoma with a massive neutrophilic infiltrate: report of a case mimicking epithelioid inflammatory myofibroblastic tumour. |
| Q38701797 | ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern |
| Q40307013 | Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion. |
| Q48528844 | Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects. |
| Q35105169 | Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials. |
| Q52746966 | Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography. |
| Q50908224 | Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding. |
| Q88003921 | Association between Activated Partial Thromboplastin Time and the Amount of Infused Heparin at Bone Marrow Transplantation |
| Q91254526 | Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation |
| Q93347096 | Blastic plasmacytoid dendritic cell neoplasm with immunoblastoid morphology and MYC rearrangement and overexpression |
| Q85205788 | Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia? |
| Q40397260 | Clinical characteristics and predictive factors for mortality in coryneform bacteria bloodstream infection in hematological patients |
| Q84406244 | Clinical course of patients with aplastic anemia or myelodysplastic syndrome associated with persistent neutropenia |
| Q39385600 | Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy. |
| Q40342256 | Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia. |
| Q43474669 | Comparison of the efficacy of peripheral blood stem cell mobilization using G-CSF alone from healthy donors and patients with hematologic malignancies. |
| Q86820967 | D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine |
| Q42914182 | Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation |
| Q33441641 | Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome |
| Q40102725 | Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma |
| Q46181753 | Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning |
| Q42208353 | Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients. |
| Q34989242 | Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides |
| Q84107949 | FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame |
| Q86874704 | False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation |
| Q40101543 | Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type |
| Q40428384 | HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin). |
| Q90713674 | Haploidentical transplantation using low-dose alemtuzumab: Comparison with haploidentical transplantation using low-dose thymoglobulin |
| Q40137330 | High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation. |
| Q41008753 | Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma |
| Q52747009 | Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation. |
| Q47189933 | Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts. |
| Q39591412 | Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation. |
| Q40922474 | Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation |
| Q52915505 | Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, L-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL. |
| Q40384599 | Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia. |
| Q92052628 | Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling |
| Q58593465 | Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation |
| Q41489633 | Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation. |
| Q52763377 | Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors. |
| Q33407822 | Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group. |
| Q34038846 | Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. |
| Q50788505 | Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation. |
| Q95380002 | Recurrence of monoclonal gammopathy associated with donor-derived myelodysplastic syndrome after cord blood stem cell transplantation |
| Q88796394 | Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response |
| Q44380574 | Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma. |
| Q33432975 | Risk Factors and Impact of Secondary Failure of Platelet Recovery After Allogeneic Stem Cell Transplantation |
| Q51780256 | Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin. |
| Q40197096 | Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia. |
| Q40739141 | Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation |
| Q64099247 | Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with locus rearrangement |
| Q44362330 | The safety and efficacy of acute graft-versus-host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL. |
| Q42245323 | Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells |
Search more.